Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and effectiveness of intrarenal
administration of brain natriuretic peptide (BNP) in improving renal function as measured by
glomerular filtration rate (GFR) and sodium excretion in patients hospitalized with acute
congestive heart failure (CHF) and deterioration of kidney function (cardiorenal syndrome).